Weijin Fang

734 total citations
39 papers, 525 citations indexed

About

Weijin Fang is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Weijin Fang has authored 39 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Weijin Fang's work include Food Allergy and Anaphylaxis Research (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Weijin Fang is often cited by papers focused on Food Allergy and Anaphylaxis Research (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Weijin Fang collaborates with scholars based in China. Weijin Fang's co-authors include Shikun Liu, Chunjiang Wang, Yang He, Xiangdong Peng, Yulu Zhou, Lingyun Zhou, Zhiqiang Fan, Wei Sun, Yan Xiong and Weilun Fang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Weijin Fang

35 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijin Fang China 10 224 106 103 91 69 39 525
Shujian Wei China 13 204 0.9× 128 1.2× 103 1.0× 63 0.7× 39 0.6× 28 493
Liqing Jiang China 13 289 1.3× 104 1.0× 186 1.8× 77 0.8× 58 0.8× 42 717
Biao Xu China 11 201 0.9× 47 0.4× 106 1.0× 75 0.8× 51 0.7× 17 445
Ya Huang China 12 173 0.8× 150 1.4× 46 0.4× 99 1.1× 62 0.9× 23 525
Nassrene Y. Elmadhun United States 15 182 0.8× 88 0.8× 138 1.3× 70 0.8× 42 0.6× 39 492
Yichao Xiao China 13 172 0.8× 88 0.8× 218 2.1× 80 0.9× 37 0.5× 56 608
Yongzheng Guo China 16 273 1.2× 70 0.7× 138 1.3× 156 1.7× 26 0.4× 34 559
Jun Feng China 18 363 1.6× 108 1.0× 39 0.4× 71 0.8× 58 0.8× 24 716
Yunfei Bian China 15 258 1.2× 121 1.1× 198 1.9× 71 0.8× 24 0.3× 38 644
Panwei Mu China 12 177 0.8× 78 0.7× 51 0.5× 71 0.8× 25 0.4× 24 449

Countries citing papers authored by Weijin Fang

Since Specialization
Citations

This map shows the geographic impact of Weijin Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijin Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijin Fang more than expected).

Fields of papers citing papers by Weijin Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijin Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijin Fang. The network helps show where Weijin Fang may publish in the future.

Co-authorship network of co-authors of Weijin Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Weijin Fang. A scholar is included among the top collaborators of Weijin Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijin Fang. Weijin Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Weilun, et al.. (2024). Clinical features, treatment, and outcome of pembrolizumab induced cholangitis. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(10). 7905–7912. 11 indexed citations
2.
Wang, Chunjiang, Hanqing Zeng, Weijin Fang, & Liying Song. (2023). Clinical characteristics, treatment and outcome of nivolumab-induced myasthenia gravis. Investigational New Drugs. 41(2). 333–339. 7 indexed citations
3.
Li, Yu, et al.. (2023). Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis. Cardiovascular Diabetology. 22(1). 25–25. 27 indexed citations
4.
Liu, Wei, et al.. (2023). Distribution of microbes and antimicrobial susceptibility in patients with diabetic foot infections in South China. Frontiers in Endocrinology. 14. 1113622–1113622. 5 indexed citations
5.
Wang, Chunjiang, et al.. (2022). Analysis of Clinical Features of Non-steroidal Anti-inflammatory Drugs Induced Kounis Syndrome. Frontiers in Cardiovascular Medicine. 9. 901522–901522. 5 indexed citations
6.
Wang, Chunjiang, et al.. (2022). Clinical features, diagnosis and management of amoxicillin-induced Kounis syndrome. Frontiers in Pharmacology. 13. 998239–998239. 2 indexed citations
7.
He, Yang, Weijin Fang, Zuojun Li, & Chunjiang Wang. (2022). Clinical features, diagnosis, and management of dasatinib-induced nephrotic syndrome. Investigational New Drugs. 40(5). 1153–1159.
8.
Deng, Zhenzhen, et al.. (2021). Analysis of clinical characteristics of Kounis syndrome induced by contrast media. The American Journal of Emergency Medicine. 52. 203–207. 7 indexed citations
9.
Li, Zuojun, et al.. (2021). Analysis of the clinical characteristics of insulin autoimmune syndrome induced by exogenous insulin in diabetic patients. Diabetology & Metabolic Syndrome. 13(1). 38–38. 8 indexed citations
10.
Xie, Yueliang, Jianglin Wang, Huiqin Yang, et al.. (2021). The risk factors for severe patients with COVID-19 in China: A systematic review and meta-analysis. SHILAP Revista de lepidopterología. 19. 2 indexed citations
11.
12.
Xiong, Yan, Weijin Fang, & Zhimin He. (2020). 458-P: Resveratrol Attenuates Diabetic Cardiomyopathy by Inhibiting Asymmetric Dimethylarginine-Induced PGC-1a Acetylation. Diabetes. 69(Supplement_1). 1 indexed citations
13.
Fang, Weijin, et al.. (2020). Analysis of the clinical characteristics of insulin autoimmune syndrome induced by methimazole. Journal of Clinical Pharmacy and Therapeutics. 46(2). 470–475. 5 indexed citations
14.
Gong, Hui, Junyu Chen, Zuojun Li, et al.. (2020). Histidine kinase NME1 and NME2 are involved in TGF-β1-induced HSC activation and CCl4-induced liver fibrosis. Journal of Molecular Histology. 51(5). 573–581. 7 indexed citations
15.
Fang, Weijin, et al.. (2020). Analysis of clinical characteristics of tigecycline‐induced acute pancreatitis. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1320–1324. 5 indexed citations
16.
Song, Liying, Weijin Fang, Yang He, et al.. (2019). Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway. BMC Complementary and Alternative Medicine. 19(1). 138–138. 20 indexed citations
17.
He, Yang, Lingyun Zhou, Zhiqiang Fan, Shikun Liu, & Weijin Fang. (2018). Palmitic acid, but not high-glucose, induced myocardial apoptosis is alleviated by N‑acetylcysteine due to attenuated mitochondrial-derived ROS accumulation-induced endoplasmic reticulum stress. Cell Death and Disease. 9(5). 568–568. 68 indexed citations
18.
Zuo, Shanru, Xiao‐cong Zuo, Yang He, et al.. (2017). Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma. Journal of Cancer. 9(2). 321–330. 36 indexed citations
19.
Fang, Weijin, Chunjiang Wang, Yang He, et al.. (2017). Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation. Acta Pharmacologica Sinica. 39(1). 59–73. 164 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shujian Wei Breakdown of academic impact, for papers by Liqing Jiang Breakdown of academic impact, for papers by Biao Xu Breakdown of academic impact, for papers by Ya Huang Breakdown of academic impact, for papers by Nassrene Y. Elmadhun Breakdown of academic impact, for papers by Yichao Xiao Breakdown of academic impact, for papers by Yongzheng Guo Breakdown of academic impact, for papers by Jun Feng Breakdown of academic impact, for papers by Yunfei Bian Breakdown of academic impact, for papers by Panwei Mu
Rankless by CCL
2026